T. Rowe Price Associates’s AlerisLife Inc ALR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,400
Closed -$21K 3068
2022
Q2
$21K Hold
17,400
﹤0.01% 2928
2022
Q1
$37K Hold
17,400
﹤0.01% 2940
2021
Q4
$51K Hold
17,400
﹤0.01% 2926
2021
Q3
$76K Hold
17,400
﹤0.01% 2880
2021
Q2
$100K Buy
17,400
+6,626
+61% +$37.7K ﹤0.01% 2849
2021
Q1
$66K Buy
+10,774
New +$77.8K ﹤0.01% 2810
2016
Q4
Sell
-3,940
Closed -$75K 2570
2016
Q3
$75K Sell
3,940
-10
-0.3% -$214 ﹤0.01% 2475
2016
Q2
$92K Hold
3,950
﹤0.01% 2435
2016
Q1
$90K Hold
3,950
﹤0.01% 2425
2015
Q4
$126K Buy
3,950
+10
+0.3% +$337 ﹤0.01% 2386
2015
Q3
$122K Hold
3,940
﹤0.01% 2385
2015
Q2
$189K Hold
3,940
﹤0.01% 2365
2015
Q1
$175K Buy
3,940
+250
+7% +$9.42K ﹤0.01% 2383
2014
Q4
$153K Hold
3,690
﹤0.01% 2412
2014
Q3
$139K Hold
3,690
﹤0.01% 2425
2014
Q2
$185K Hold
3,690
﹤0.01% 2370
2014
Q1
$179K Hold
3,690
﹤0.01% 2348
2013
Q4
$203K Hold
3,690
﹤0.01% 2313
2013
Q3
$191K Hold
3,690
﹤0.01% 2278
2013
Q2
$207K Buy
+3,690
New +$201K ﹤0.01% 2203

Other funds holding ALR

T. Rowe Price Associates's ALR Position: Q3 2022 in Review

T. Rowe Price Associates sold out of AlerisLife Inc (ALR) in Q3 2022, closing a stake of 17,400 shares — an estimated $21K sold.

T. Rowe Price Associates first reported a position in ALR in Q2 2013 and held it in 20 quarters. The position peaked at $207K in Q2 2013. 67 funds tracked by Wall St. Rank hold ALR as of Q3 2022.

  • T. Rowe Price Associates reported no remaining AlerisLife Inc position as of Q3 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 17,400 AlerisLife Inc shares in Q3 2022, an estimated $21K.
  • T. Rowe Price Associates first reported a position in AlerisLife Inc in Q2 2013 and held it in 20 quarters.
  • T. Rowe Price Associates's AlerisLife Inc position peaked at $207K in Q2 2013.
  • 67 funds tracked by Wall St. Rank held AlerisLife Inc as of Q3 2022.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.